Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...
Pfizer's stock underperformed its healthcare peers since PFE topped out in late July 2024. Click here to find out why I ...
Pharmaceutical giant Pfizer ( PFE 2.73%) stands out in this context. The company currently offers a mouthwatering 5.7% ...
Pfizer purchased a stunning amount of radio ads as the company urges getting COVID-19 booster shots and flu vaccinations ...
Pfizer is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug ...
Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...
Health Canada has approved Pfizer-BioNTech’s updated COVID-19 vaccine that protects against one of the most recently ...
Financial giants have made a conspicuous bearish move on Pfizer. Our analysis of options history for Pfizer PFE revealed ...
We recently compiled a list of the 8 Best Wide Moat Stocks to Buy According to Analysts. In this article, we are going to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback